Cocer PeptidesTesamorelin
Ordered Tesamorelin from Cocer Peptides? Mail in a sample (US only) and let us test it for free.
Test my supplyLarge overfills, not identity or purity, drive Cocer Peptides' Tesamorelin rating: +50% in February and +42% in June exceeded this method's fill window. The latest result keeps the trajectory mixed rather than clean.
WHOIS and domain evidence test Cocer’s experience claims while mapping a fragmented brand surface, including a confirmed .top impersonation and a shifting .net storefront. The report also traces self-submitted COAs, fake-tracking complaints, and weak recourse rails.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including Cocer Peptides rows.
Cancel anytime
About Cocer Peptides test results from Finnrick
Cocer Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 9 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible Cocer Peptides peptides in this dataset are Retatrutide (5 tests), Tesamorelin (4 tests) and BPC-157 (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 9 recent tests.
Ordered Tesamorelin from Cocer Peptides? Mail in a sample (US only) and let us test it for free.
Test my supply